Key Takeaways

The U.S. Food and Drug Administration is conducting a safety review of the abortion pill mifepristone

The review comes after conservative and anti-abortion groups raised concerns about the drug and access to it

The review may alter how the drug is prescribed, but an outright ban is unlikely

MONDAY, Sept. 29, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) is reviewing the safety of mifepristone, a drug used in medication abortions for 25 years, amid a push from conservative state attorneys general and anti-abortion groups.

The announcement was made in a letter from Health and Human Services Secretary Robert F. Kennedy Jr , according to CBS News .

The review, spearheaded by Kennedy, focuses on compliance with an FDA safety program aimed at ensur

See Full Page